Purpose: Nocturia is common and bothersome in older adults, especially those who are also incontinent. Since nocturnal polyuria is a major contributor, we examined factors associated with nocturnal polyuria in this population to identify those possibly amenable to intervention. Materials and Methods: We analyzed baseline data from 2 previously completed studies of urge urinary incontinence. The studies involved 284 women (mean age AE SD 72.9 AE 7.9 years) who also completed 3-day voiding diaries. Participants with a nocturnal polyuria index greater than 33% were categorized as having nocturnal polyuria (nocturnal polyuria index ¼ nocturnal urinary volume per 24-hour urine volume). Associations between nocturnal polyuria and various demographic, clinical and sleep related parameters were determined. Results: Overall 55% of the participants had nocturnal polyuria. Multivariable regression analysis revealed that age, body mass index, use of angiotensin converting enzyme inhibitor/angiotensin receptor blocker, time spent in bed and duration of first uninterrupted sleep were independent correlates of nocturnal polyuria. Participants with a larger nocturnal excretion reported a shorter duration of uninterrupted sleep before first awakening to void and worse sleep quality despite spending similar time in bed. Conclusions: Body mass index, use of angiotensin converting enzyme inhibitor/ angiotensin receptor blockers, time in bed and duration of uninterrupted sleep before first awakening to void are independently associated with nocturnal polyuria in older women with urge urinary incontinence, and are potentially modifiable. These findings also confirm the association between sleep and nocturnal polyuria. Further studies should explore whether interventions to reduce nocturnal polyuria and/or increase the duration of uninterrupted sleep before first awakening to void would help to improve sleep quality in this population and thereby reduce or eliminate the need for sedative hypnotics.
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NOCTURIA is one of the most common and bothersome lower urinary tract symptoms. 1 It is defined by the ICS as waking at least once nightly to void, with each void preceded and followed by sleep. 2 The prevalence of nocturia increases significantly with age, affecting approximately 70% among individuals older than 60 years. 3 Studies identify 4 pathophysiological mechanisms for nocturia, namely nocturnal polyuria, 24-hour polyuria, decreased bladder capacity and sleep disorders. 1, 4 Of these, NP is the most common, 5 and it is defined as nocturnal output that exceeds 33% of total daily urine production. 2 Its pathophysiology among older adults remains poorly understood and is a major impediment to improving therapy. 2 Nocturnal mobilization of peripheral edema, sleep apnea or fluid overload conditions such as poorly controlled diabetes and heart failure contribute to NP in the elderly, but its etiology in the absence of these factors is not clear. 4, 6 NP is inextricably related to sleep but the nature of this relationship in the elderly is complex and not fully understood. NP is related to time spent in bed, as people spending prolonged time in bed have a proportionately higher NUV, but most studies of NP lack information about the duration of time spent in bed. In addition, the role of sleep quality in nocturnal urine production in the elderly is not known. Studies in young adults have revealed that NUP is strongly influenced by sleep stages. Excretion of water, electrolytes and other osmotically active substances decreases substantially during the deepest stage of sleep (NREM or slow wave sleep). NREM predominates in the first 3 to 4 hours of sleep, and sleep interruption during NREM alters renal water/salt excretion and increases NUV. Such disruption may contribute to insomnia, which is prevalent in the elderly, especially sleep maintenance insomnia. At the same time the impact of poor sleep quality and frequent sleep interruptions on NUP among the elderly is not known.
In addition to sleep, several other age related factors such as comorbidity, medications and renal sodium handling may impact NP in the elderly, but to our knowledge this has not been studied in this population. To address these knowledge gaps we conducted a secondary analysis of 2 recently completed studies of urge urinary incontinence.
11,12
METHODS
Study Design
This study is a secondary analysis of baseline data from 2 NIH (National Institutes of Health) funded prospective studies of older women with UUI. The parent studies were designed to identify the factors that predict and mediate the therapeutic response to biofeedback, and to evaluate brain responses to bladder filling before and after intervention.
Participants
Study procedures have been described previously. 11, 12 Participants were cognitively intact, functionally independent, community dwelling women age 60 or older. All had at least 5 UUI episodes per week for at least 3 months despite correction of potentially reversible causes. All were able to complete a voiding diary accurately and to understand instructions in biofeedback sessions. Both studies were approved by the University of Pittsburgh institutional review board and all participants provided written informed consent.
Women with significant mental or cognitive impairment (Mini-Mental State Examination score less than 24) that could have prevented them from adhering to the study protocol were excluded from the study, as were women with a history of bladder cancer, spinal cord lesion, multiple sclerosis, pelvic radiation, interstitial cystitis, urethral obstruction, urinary retention (post-void residual greater than 200 ml after noninstrumented void), clinically apparent neurological lesion and those who were medically unstable.
Clinical Assessment
All participants who completed a baseline evaluation were included in the current analysis. Baseline evaluation included detailed medical and voiding/incontinence history and a comprehensive physical examination including neurological, cognitive and stress incontinence testing.
For this analysis we reviewed data from the baseline 3-day bladder diary completed by each participant. Diaries included the time and volume of each void, as well as the times the subjects awoke and went to sleep each day. The first void after waking was included in the NUV. The nocturnal polyuria index was calculated by dividing NUV by 24-hour urine volume. To categorize the participants with NP we not only used the ICS definition of NPi of greater than 33%, 2 but also an alternative threshold of NPi of greater than 53%. 13 Participants with a 24-hour urine volume greater than 40 ml/kg body weight were classified as having 24-hour polyuria. 2 Time in bed was defined as the interval between going to bed with the intent of sleeping and getting up for the day, and it was obtained using the times recorded in the 3-day bladder diary. Duration of uninterrupted sleep before first awakening to void was defined as the interval between the times marked in the bladder diary as going to bed with the intent of sleeping and the first awakening to void.
The short form of the Center for Epidemiologic Studies Depression Scale was completed by participants at baseline. Because the focus of the parent study was incontinence and there were no specific sleep related questionnaires, we used the sleep restlessness question from the CES-D as a proxy measure for sleep quality. This question assessed sleep restlessness during the last week, with scores ranging from 0 to 3 for rarely (less than 1 day), some of the time (1 to 2 days), occasionally (3 to 4 days) and all of the time (5 to 7 days), respectively.
Statistical Analysis
We used the independent sample t-test and chi-square test, respectively, to compare continuous and categorical data among participants with and without NP. Multiple regression analysis with a stepwise selection approach was used to obtain a parsimonious set of variables correlated with NPi. Candidate predictor variables included age, BMI, tobacco and alcohol use, albumin level, creatinine, presence of peripheral edema and bladder diary variables, including 24-hour urine volume, mean awake voided volume, FBC, time in bed and DUS. Medications were also considered, including the use of ACE-I/ ARBs, diuretics, calcium channel blockers, anticholinergics, antidepressants and nonsteroidal anti-inflammatory drugs.
Using a subset of participants with available CES-D scores, we compared NPi, DUS and time in bed across self-rated categories of restless sleep ratings using analysis of variance. SAS Ò version 9.3 was used for all statistical analyses.
RESULTS
Demographic and 3-day bladder diary data are displayed in tables 1 and 2, respectively. Participant age ranged from 60 to 93 years. In this cohort of elderly women with UUI 65% had more than 1 nocturnal void per night and 55% met the ICS definition of NP. Demographic factors were comparable between those with and those without NP, as were bladder diary variables such as 24-hour urine output and daytime FBC. However, NBC was significantly higher in those with NP (table 2) . Despite a higher NBC, the first nighttime voided volume among those with NP was significantly lower (226AE80 vs 282AE90, p¼0.0004, fig. 1 ). Compared to those without NP, participants with NP spent significantly more total time in bed and had a shorter DUS.
Multivariable stepwise regression revealed that increased NPi was associated independently with advancing age, higher BMI, longer time in bed, shorter DUS and nonuse of an ACE-I/ARB (table 3) . Results remained the same regardless of the NPi threshold used to define nocturnal polyuria. Participants with a shorter DUS reported worse sleep quality (table 4, fig. 2 ). Across the scale of worsening sleep restlessness an inverse relationship was seen between DUS and NPi. Participants with a shorter DUS reported worse sleep quality and had a higher NPi despite a similar time in bed.
DISCUSSION
NP affected more than half of these fairly healthy, cognitively intact, older women with UUI. It was independently associated with advancing age, higher BMI, longer time in bed, shorter DUS and nonuse of an ACE-I/ARB medication. In addition, after controlling for time in bed, longer DUS correlated with better sleep quality and lower NPi. To our knowledge, this study is the first to concurrently examine the impact of sleep, fluid excretion and lower urinary tract function on NP. By focusing on the independent contribution and relative importance of common and potentially modifiable clinical factors, the study also sets the stage for a prospective evaluation of a multifaceted intervention.
An association of NP with age and BMI was not surprising. NP in the elderly arises from a complex interaction of several pathophysiological processes involving the lower urinary tract, renal function and sleep. Aging adversely impacts each of these systems to different degrees and the circadian rhythm of urinary excretion is disrupted with age. 14 Higher BMI has also been associated with increased frequency of nocturia and higher NPi independent of underlying sleep apnea. 15, 16 Our study also confirmed time in bed as an independent predictor of NP. 17, 18 Prolonged time in bed is associated with insomnia in this age group. 19 Increased time in bed likely reflects an effort by the individual with frequent awakenings to catch up on sleep, but the increased attention and effort to sleep may increase brain activity and perpetuate insomnia. 20 Physiological and sensory hyperarousal in older adults with insomnia 21 may also make them more aware of bladder fullness and lead to frequent awakenings to void. Thus, the interplay of nocturia and sleep could lead to increased time in bed, and proportionately the volume of urine produced while in bed may increase. In such cases nocturia and NP may be a consequence of poor sleep. Additionally, the smaller volume of the first nighttime void among nocturics with NP in our cohort suggests that the awakening may be related to poor sleep rather than to the volume in the bladder.
Another interesting finding of our study is the difference in DUS between those with and without NP. DUS was an hour shorter among those with NP. With similar time in bed, participants with a shorter DUS reported worse sleep quality and had a higher NPi. Thus, DUS may explain the relationship between NP and sleep quality, and increasing DUS through decreasing NPi could be a potential target for improving sleep quality and decreasing the nocturia burden among older adults. 22, 23 These findings suggest a bidirectional relationship between sleep and nocturia. So, too, does our earlier study, which revealed that a behavioral approach to insomnia reduced nocturia. 24 The physiological rhythm of urine production is governed by a variety of hormones that regulate salt and water excretion, including vasopressin, renin, aldosterone, angiotensin and atrial natriuretic peptide. Studies in young adults have shown that secretion of these hormones is strongly influenced by sleep stages, especially slow wave sleep, which predominates in the first half of the night. 7, 8 Sleep deprivation and disruption of slow wave sleep blunt the nocturnal surge in secretion of these hormones and, thus, contribute to natriuresis and diuresis. 9, 10 Our results, which show an association among early awakenings, poor sleep quality and higher NPi, support the argument that sleep and NP may have a bidirectional relationship in the elderly as well. However, we were unable to assess formal sleep, electrolyte or hormonal levels in the available data set.
We also found evidence that the use of ACE-I/ ARB is associated with a lower NPi. A possible explanation may be the benefit of ACE-I/ARB on renal health. An age related decrease in renal function and urine concentrating ability is thought to contribute to NP. 25 The renin-angiotensinaldosterone system has a major role in renal function, and renin-angiotensin-aldosterone system blockade with ARBs and ACE-I slows the progression of renal disease. 26 Although one of the direct effects of angiotensin II blockade is natriuresis, the overall renal protective effect of ACE-I/ARB may have long-term benefit for older adults with nocturia. A large NIH survey recently reported benefits of ACE-I/ARB in men with UUI but not in women, but the study did not assess the effect of ACE-I/ARB on NP or its impact on nocturia. 27 Our study has several strengths. The primary studies collected detailed demographic and clinical data on every participant and, thus, provide a unique opportunity to analyze the objective bladder diary data combined with detailed clinical information. In addition, we used the internationally standardized definition of NP as well as an alternative definition, and both yielded the same results. We did not use other possible definitions of NP, for example nocturnal urine production greater than 90 ml per hour, or nocturia index greater than 1, 13 since each has limitations. For instance, the NUP criterion ignores urine production during the day and presumes that urine output is constant between 1 a.m. and 6 a.m. Yet studies have shown that nighttime urine output is not constant, but varies depending on sleep stage which, in turn, regulates the rhythm of renal regulatory hormones. 7, 8 Similarly, the definition of nocturia index greater than 1 reflects the association between bladder capacity and nocturnal urinary volume rather than nocturnal polyuria.
Our study also has some limitations. Although various studies exploring the etiology of lower urinary tract symptoms in the elderly have shown similar results, 5, 17, 18 because our study included only older women with UUI, its applicability is unknown for the older population in general, ie women without UUI or men. In addition, since UUI was the focus of the primary study, the effect of underlying detrusor overactivity on nocturia cannot be excluded. The impact of DO on nocturia is controversial. Krystal et al showed that DO contributed to the pathophysiology of nocturia, 28 but nocturnal DO preceding nocturia was demonstrated in less than half of the nocturia events. The limited response of nocturia to treatment with anticholinergic medications further suggests that even in patients with UUI and nocturia, it is likely that nocturia is more often related to an etiology other than DO. 29 Sleep apnea is also a known risk factor for poor sleep and NP. 1, 5 Since the primary study focused on UUI, formal sleep apnea assessments were not completed. However, a detailed medical history was obtained from each participant and none had a diagnosis of sleep apnea or used continuous positive airway pressure treatment. Higher BMI is a risk factor for obstructive sleep apnea, and BMI was comparable among nocturics with and without NP. Finally, since the primary studies were not designed to examine sleep duration, state or quality, we cannot determine whether participants with prolonged time in bed or self-reported poor sleep quality had sleep related difficulties. Nevertheless, our findings concur with those of previous studies suggesting prolonged time in bed as a prominent cause of geriatric insomnia. 30 
CONCLUSIONS
Our study of older women with urge incontinence suggests that advancing age, higher BMI and prolonged time spent in bed are independently associated with higher NPi, and that longer DUS and use of ACE-I/ARB are independently associated with lower NPi. In addition, longer DUS correlates with better sleep quality in this population. Future studies of NP should assess the impact of simple interventions to increase DUS and consolidate sleep (eg mild restriction of bed time) as part of the therapeutic approach to such patients. 
